Carlos Telleria

ORCID: 0000-0001-8799-9010 · 10 papers in corpus
review 2014
Reproduction (Cambridge, England) ·doi:10.1530/rep-14-0416

Antiprogestins constitute a group of compounds, developed since the early 1980s, that bind progesterone receptors with different affinities. The first clinical uses for antiprogestins were in reproductive medicine, e.g., menstrual regulatio…

article 2014
·doi:10.1071/rd14184

There is considerable evidence of the neuroendocrine control involved in luteal regression in the rat. In addition, circulating prolactin (PRL), which increases during the night before parturition, may gain access to the coeliac ganglion (C…

2013
BMC cancer ·doi:10.1186/1471-2407-13-35

BackgroundChanges in cell shape and plasticity in cytoskeletal dynamics are critically involved in cell adhesion, migration, invasion and the overall process of metastasis. Previous work in our laboratory demonstrated that the synthetic ste…

2013
Cancer growth and metastasis ·doi:10.4137/cgm.s11124

We have previously shown that the antiprogestin and antiglucocorticoid mifepristone inhibits the growth of ovarian cancer cells. In this work, we hypothesized that cellular stress caused by mifepristone is limited to cytostasis and that cel…

2012
Journal of cancer science & therapy ·doi:10.4172/1948-5956.1000e108
2012
Investigational new drugs ·doi:10.1007/s10637-011-9655-z

Antiprogestins have been largely utilized in reproductive medicine, yet their repositioning for oncologic use is rapidly emerging. In this study we investigated the molecular mediators of the anti-ovarian cancer activity of the structurally…

2011
BMC cancer ·doi:10.1186/1471-2407-11-207

BackgroundMifepristone (MF) has been largely used in reproductive medicine due to its capacity to modulate the progesterone receptor (PR). The study of MF has been expanded to the field of oncology; yet it remains unclear whether the expres…

2009
International journal of oncology ·doi:10.3892/ijo_00000200

Repopulation of cancer cells escaping lethal chemotherapy is a critical factor hindering treatment success. One strategy to inhibit tumor cell repopulation is the use of cytostatic compounds between courses of lethal chemotherapy. In this s…

2007
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-07-0164

PurposeThese studies were designed to determine whether the synthetic steroid mifepristone inhibits ovarian cancer growth in vitro and in vivo and the molecular mechanisms involved.Experimental designThe effect of mifepristone on ovarian ca…

article 2004
·doi:10.1186/1477-7827-2-22

BACKGROUND: In the rat, the maintenance of gestation is dependent on progesterone production from the corpora lutea (CL), which are under the control of pituitary, decidual and placental hormones. The luteal metabolism of progesterone durin…